DERMIRA INC's ticker is DERM and the CUSIP is 24983L104. A total of 137 filers reported holding DERMIRA INC in Q4 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $381,000 | -84.4% | 25,103 | -86.1% | 0.00% | -84.2% |
Q1 2019 | $2,449,000 | +747.4% | 180,732 | +349.2% | 0.02% | +850.0% |
Q4 2018 | $289,000 | +48.2% | 40,237 | +124.4% | 0.00% | +100.0% |
Q3 2018 | $195,000 | -14.1% | 17,934 | -36.8% | 0.00% | 0.0% |
Q1 2018 | $227,000 | +372.9% | 28,392 | +1928.0% | 0.00% | – |
Q4 2015 | $48,000 | – | 1,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ORACLE INVESTMENT MANAGEMENT INC | 1,760,072 | $16,826,000 | 3.62% |
NEA Management Company, LLC | 3,506,649 | $33,524,000 | 2.35% |
GREAT POINT PARTNERS LLC | 1,552,900 | $14,846,000,000 | 1.65% |
APIS CAPITAL ADVISORS, LLC | 100,000 | $956,000 | 1.43% |
NEXTHERA CAPITAL LP | 138,102 | $1,320,000 | 1.10% |
Eversept Partners, LP | 399,874 | $3,822,795 | 1.07% |
Jeneq Management LP | 96,570 | $923,000 | 0.82% |
Trellus Management Company, LLC | 60,000 | $574,000 | 0.78% |
PFM Health Sciences, LP | 4,044,542 | $38,666,000 | 0.73% |
Birchview Capital, LP | 120,000 | $1,147,000 | 0.70% |